loadpatents
name:-0.024345874786377
name:-0.016661882400513
name:-0.00043320655822754
Gadhachanda; Venkat Patent Filings

Gadhachanda; Venkat

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gadhachanda; Venkat.The latest application filed is for "subsituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections".

Company Profile
0.18.19
  • Gadhachanda; Venkat - Hamden CT
  • Gadhachanda; Venkat - Branford CT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Subsituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20180303800 - Wiles; Jason Allan ;   et al.
2018-10-25
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero- heteraphanes and metallocenes useful for treating HCV infections
Grant 10,092,547 - Wiles , et al. October 9, 2
2018-10-09
Substituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20180055824 - Wiles; Jason Allan ;   et al.
2018-03-01
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
Grant 9,833,440 - Wiles , et al. December 5, 2
2017-12-05
Substituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20170157096 - Wiles; Jason Allan ;   et al.
2017-06-08
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
Grant 9,592,222 - Wiles , et al. March 14, 2
2017-03-14
Substituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20170007579 - Wiles; Jason Allan ;   et al.
2017-01-12
Process for producing Sovaprevir
Grant 9,481,708 - Phadke , et al. November 1, 2
2016-11-01
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
Grant 9,474,742 - Wiles , et al. October 25, 2
2016-10-25
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
Grant 9,468,629 - Wiles , et al. October 18, 2
2016-10-18
Substituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20160115157 - Wiles; Jason Allan ;   et al.
2016-04-28
Substituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20160113907 - Wiles; Jason Allan ;   et al.
2016-04-28
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
Grant 9,273,082 - Wiles , et al. March 1, 2
2016-03-01
Novel Process For Producing Sovaprevir
App 20150322109 - Phadke; Avinash ;   et al.
2015-11-12
Biphenyl imidazoles and related compounds useful for treating HCV infections
Grant 9,125,904 - Wiles , et al. September 8, 2
2015-09-08
Processes for Producing sovaprevir
Grant 9,115,175 - Phadke , et al. August 25, 2
2015-08-25
Substituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20140323458 - Wiles; Jason Allan ;   et al.
2014-10-30
Novel Processes For Producing Sovaprevir
App 20140275480 - Phadke; Avinash ;   et al.
2014-09-18
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
Grant 8,809,313 - Wiles , et al. August 19, 2
2014-08-19
4-amino-4-oxobutanoyl Peptide Cyclic Analogues, Inhibitors Of Viral Replication
App 20140206604 - Phadke; Avinash ;   et al.
2014-07-24
New 4-amino-4-oxobutanoyl Peptides As Inhibitors Of Viral Replication
App 20140113890 - Phadke; Avinash ;   et al.
2014-04-24
4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
Grant 8,614,180 - Phadke , et al. December 24, 2
2013-12-24
Cyclic carboxamide compounds and analogues thereof as of hepatitis C virus
Grant 8,445,430 - Zhang , et al. May 21, 2
2013-05-21
Subsituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20120302538 - Wiles; Jason Allan ;   et al.
2012-11-29
Heteroaryl substituted thiazoles
Grant 8,183,263 - Wang , et al. May 22, 2
2012-05-22
Thiazole Compounds And Methods Of Use
App 20120108576 - Zhang; Suoming ;   et al.
2012-05-03
Thiazole compounds and methods of use
Grant 8,088,806 - Zhang , et al. January 3, 2
2012-01-03
4-amino-4-oxobutanoyl Peptides As Inhibitors Of Viral Replication
App 20100216725 - Phadke; Avinash ;   et al.
2010-08-26
4-amino-4-oxobutanoyl Peptide Cyclic Analogues, Inhibitors Of Viral Replication
App 20100152103 - Phadke; Avinash ;   et al.
2010-06-17
Cyclic Carboxamide Compounds And Analogues Thereof As Of Hepatitis C Virus
App 20100124545 - Zhang; Suoming ;   et al.
2010-05-20
Heteroaryl Substituted Thiazoles
App 20090041720 - Wang; Xiangzhu ;   et al.
2009-02-12
Thiazole compounds and methods of use
App 20070004711 - Zhang; Suoming ;   et al.
2007-01-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed